RYANE P DOTY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health JACKSON, MS NPI 1528531985

General Payments — all program years on this page

$1,373.73

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 37
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $844.46 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $844.4619

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $139.347
2022 $30.282
2023 $359.659
2024 $844.4619

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078066044 Janssen Pharmaceuticals, Inc $29.81 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101398653 E.R. Squibb & Sons, L.L.C. $18.53 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118841519 Otsuka Pharmaceutical Development & Commercialization, Inc. $88.55 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119061060 Otsuka America Pharmaceutical, Inc. $20.87 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119061062 Otsuka America Pharmaceutical, Inc. $21.06 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119061064 Otsuka America Pharmaceutical, Inc. $124.26 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119061066 Otsuka America Pharmaceutical, Inc. $10.83 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133940114 Vanda Pharmaceuticals Inc. $83.78 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133940116 Vanda Pharmaceuticals Inc. $38.66 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144550375 Indivior Inc. $17.34 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144550377 Indivior Inc. $21.48 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144550379 Indivior Inc. $17.63 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144550381 Indivior Inc. $30.74 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144550383 Indivior Inc. $18.07 06/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144550385 Indivior Inc. $22.15 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144550387 Indivior Inc. $22.78 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147892058 Supernus Pharmaceuticals, Inc. $14.55 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147892060 Supernus Pharmaceuticals, Inc. $123.12 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148405355 Axsome Therapeutics, Inc. $120.25 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.